alpha-conotoxin imi has been researched along with docetaxel anhydrous in 1 studies
| Studies (alpha-conotoxin imi) | Trials (alpha-conotoxin imi) | Recent Studies (post-2010) (alpha-conotoxin imi) | Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) |
|---|---|---|---|---|---|
| 46 | 0 | 9 | 12,110 | 3,216 | 6,920 |
| Protein | Taxonomy | alpha-conotoxin imi (IC50) | docetaxel anhydrous (IC50) |
|---|---|---|---|
| Kinesin-like protein KIF11 | Homo sapiens (human) | 0.0014 | |
| Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 5.0119 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Mei, D; Ni, X; Wang, X; Yu, Z; Zhang, Q; Zhang, X; Zhao, L | 1 |
1 other study(ies) available for alpha-conotoxin imi and docetaxel anhydrous
| Article | Year |
|---|---|
α-Conotoxin ImI-modified polymeric micelles as potential nanocarriers for targeted docetaxel delivery to α7-nAChR overexpressed non-small cell lung cancer.
Topics: A549 Cells; alpha7 Nicotinic Acetylcholine Receptor; Animals; Carcinoma, Non-Small-Cell Lung; Conotoxins; Docetaxel; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Micelles; Nanocapsules; Polymers; Random Allocation; Taxoids | 2018 |